CTO of $AMRZ buys 2,000 shares in insider purchase

The Chief Technology Officer of $AMRZ recently engaged in insider trading by purchasing 2,000 shares of the company on 08-27-2025, totaling an estimated $103,760. Quiver Quantitative, using data from recent SEC filings, reported this trade. This acquisition increased their ownership of this class of stock by about 66.7%, bringing their total holdings to 5,000 shares of $AMRZ stock.

Over the past six months, $AMRZ insiders have been actively involved in trading the company’s stock, with 50 total transactions occurring on the open market. All 50 of these trades were purchases, with no sales recorded within this period. Notable individuals within the company who have engaged in recent insider trading include JAN PHILIPP JENISCH, MARIO GROSS, IAN A JOHNSTON, JAIME HILL, STEPHEN S CLARK, ROALD BROUWER, DENISE R SINGLETON, and SAMUEL JONAS POLETTI. These insiders have made multiple purchases of shares, contributing to the positive activity seen in $AMRZ stock trading.

In terms of analyst ratings, Wall Street has been bullish on $AMRZ in recent months, with 4 firms issuing buy ratings and 0 firms issuing sell ratings. Notable recent analyst ratings include an “Overweight” rating from JP Morgan, an “Outperform” rating from RBC Capital, a “Buy” rating from Truist Securities, and an “Overweight” rating from Morgan Stanley. Analysts’ positive outlook on $AMRZ reflects optimism in the company’s potential for growth and success.

Many analysts have also provided price targets for $AMRZ in recent months, with the median target set at $58.5. Some of the recent price targets from analysts include $60.0 from Adrian Huerta at JP Morgan, $54.0 from Anthony Codling at RBC Capital, $62.0 from Pujarini Ghosh at Bernstein, $57.0 from Jerry Revich at Goldman Sachs, $56.0 from Arnaud Lehmann at B of A Securities, $60.0 from Keith Hughes at Truist Securities, and $62.0 from Cedar Ekblom at Morgan Stanley. These price targets indicate the range of expectations analysts have for the stock’s performance in the coming months.

It is important to note that this article does not provide financial advice and should be considered for informational purposes only. For further information and disclaimers, consult Quiver Quantitative’s policies and guidelines.